in Patients down with Migraine without Auras The authors evaluated the effectivity of treatment of single migrainous attacks with zolmitriptan. The cohort of patients was comprised of 20 patients with common migraine, suffering from medium or serious attacks predominantly with a frequency of 1-2 times per month, who were not treated by prophylaxis, suffering no other disease. The patients were chosen from a total number of 206 migraine patients from a headache center. The age of the patients ranged from 18 to 50 years, average age was 33.1 years. There were 18 females and 2 males. Zolmitriptan was evaluated as effective, well tolerated with maximally 10% of recurrent headache, which had to be treated with repeated drug doses.

        Key words: common migraine - serotonin - zolmitriptan.